Rationale of personalized immunosuppressive medication for hepatocellular carcinoma patients after liver transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rationale of personalized immunosuppressive medication for hepatocellular carcinoma patients after liver transplantation

Published:2014-01-27 Issue:3 Volume:20 Page:261-269
ISSN:1527-6465
Container-title:Liver Transplantation
language:en
Short-container-title:Liver Transpl

Author:

Chen Kan¹²,Man Kwan³,Metselaar Herold J.²,Janssen Harry L. A.²⁴,Peppelenbosch Maikel P.²,Pan Qiuwei²

Affiliation:

1. Bio-X Center, College of Life Sciences; Zhejiang Sci-Tech University; Hangzhou China

2. Department of Gastroenterology and Hepatology; Erasmus MC-University Medical Center; Rotterdam the Netherlands

3. Department of Surgery; Hong Kong University; Hong Kong China

4. Division of Gastroenterology; University Health Network; Toronto Canada

Publisher

Wiley

Subject

Transplantation,Hepatology,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.23806/fullpdf

Reference96 articles.

1. Hepatocellular carcinoma: management of an increasingly common problem;Davis;Proc (Bayl Univ Med Cent),2008

2. for OLT for HCC Consensus Group. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report;Clavien;Lancet Oncol,2012

3. Cancer after kidney transplantation in the United States;Kasiske;Am J Transplant,2004

4. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age;Tjon;Liver Transpl,2010

5. Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression;Vivarelli;Liver Transpl,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statin Use and Hepatocellular Carcinoma Risk: A Comprehensive Meta- Analysis and Systematic Review;Recent Patents on Anti-Cancer Drug Discovery;2024-01-26

2. Predictors of post-recurrence survival in hepatocellular carcinoma patients following liver transplantation: Systematic review and meta-analysis;Transplantation Reviews;2022-01

3. Validation of Risk Estimation of Tumor Recurrence After Transplant Score in Patients With Hepatocellular Carcinoma Treated by Liver Transplant;Experimental and Clinical Transplantation;2021-12

4. Sirolimus and MMF are insufficient immunosuppressants for regulation of the proliferation of CD133+EpCAM+ cell populations in HCC cell lines;Biomedical Reports;2020-10-20

5. Doxorubicin hydrochloride enhanced antitumour effect of CEA‐regulated oncolytic virotherapy in live cancer cells and a mouse model;Journal of Cellular and Molecular Medicine;2020-10-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3